Stock listing

KRX:196170 Alteogen Inc. (알테오젠) 주가

Follow Alteogen Inc. into a list and get an email when it puts out news.

Share price · KRX:196170

₩174,400 KRW +3,500 (+2.0%)

Close on Nov 20, 2026

Past year -59.3% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
₩171,500 – ₩181,700 KRWNov 20, 2026
Volume
606,458 sharesNov 20, 2026
Market cap
₩12.12T KRWAt the close on Nov 20, 2026 · price × 69.51M shares outstanding
52-week range
₩152,500 – ₩424,616 KRWLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
₩116.0B KRWMedian day 335,825 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Alteogen Inc. logo

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · KRX:196170 · KRW, adjusted for splits

DayCloseChange%OpenHighLowVolume
₩174,400+3,500+2.0%₩172,800₩181,700₩171,500606,458
₩170,900-2,100-1.2%₩173,100₩177,000₩168,700272,904
₩173,000+1,300+0.8%₩169,700₩177,100₩168,100252,866
₩171,700-4,500-2.6%₩178,000₩180,700₩171,100218,880
₩176,200-1,200-0.7%₩177,500₩187,900₩175,500442,277
₩177,400-6,100-3.3%₩181,400₩184,700₩174,400421,301
₩183,500+7,200+4.1%₩175,000₩186,500₩173,400517,975
₩176,300+7,900+4.7%₩173,400₩181,900₩172,500651,815
₩168,400-32,100-16.0%₩196,000₩198,300₩152,5002,714,874
₩200,500-11,000-5.2%₩194,400₩204,000₩193,600427,896
₩211,500+7,500+3.7%₩213,500₩224,000₩209,500507,164
₩204,000-9,500-4.4%₩213,500₩213,500₩193,100729,315
₩213,500+500+0.2%₩209,500₩220,500₩209,500278,651
₩213,000+1,500+0.7%₩206,500₩216,500₩206,500183,151
₩211,500-8,500-3.9%₩222,500₩223,000₩208,500320,978
₩220,000-3,000-1.3%₩225,000₩226,500₩216,500225,094
₩223,000+4,500+2.1%₩219,500₩228,500₩219,000230,809
₩218,50000.0%₩220,500₩229,500₩217,000224,003
₩218,500-6,000-2.7%₩217,000₩224,500₩216,500155,196
₩224,500-6,500-2.8%₩227,500₩229,000₩220,500229,076
₩231,000-9,000-3.8%₩238,500₩239,000₩229,000168,685
₩240,000+9,000+3.9%₩236,000₩243,500₩235,000248,776
₩231,000-8,000-3.3%₩233,500₩238,000₩226,000205,001
₩239,000+5,000+2.1%₩232,000₩239,000₩229,000264,953
₩234,000+20,500+9.6%₩214,500₩240,500₩214,500546,934
₩213,500-11,000-4.9%₩214,000₩218,000₩209,000392,922
₩224,50000.0%₩223,500₩229,500₩222,000260,527
₩224,500-7,000-3.0%₩220,000₩228,000₩217,500397,458
₩231,500-9,500-3.9%₩238,000₩241,000₩230,000346,024
₩241,000-16,000-6.2%₩239,000₩246,000₩234,500724,009
₩257,000-3,000-1.2%₩265,000₩265,500₩256,500235,563
₩260,000+500+0.2%₩259,000₩266,500₩256,500281,458
₩259,500-5,500-2.1%₩263,500₩268,000₩257,000234,723
₩265,000+10,500+4.1%₩253,500₩266,000₩251,500413,327
₩254,500+1,000+0.4%₩253,500₩259,500₩252,500229,571
₩253,500+1,000+0.4%₩250,000₩255,000₩244,000297,353
₩252,500+2,500+1.0%₩256,500₩260,000₩251,500270,647
₩250,000+500+0.2%₩250,000₩257,500₩248,500222,524
₩249,500-5,500-2.2%₩257,000₩257,500₩248,500276,847
₩255,000+1,500+0.6%₩255,500₩260,000₩253,500193,075
₩253,500-500-0.2%₩256,000₩258,000₩252,500216,543
₩254,000-1,500-0.6%₩258,500₩260,000₩252,000205,493
₩255,500-4,500-1.7%₩258,000₩260,000₩250,500325,625
₩260,00000.0%₩262,000₩267,500₩258,500266,955
₩260,000-8,000-3.0%₩262,000₩263,000₩258,000403,038
₩268,000-9,000-3.2%₩268,000₩271,500₩265,000442,647
₩277,000-2,500-0.9%₩274,500₩279,000₩268,000655,737
₩279,500+2,500+0.9%₩270,000₩280,500₩268,500544,699
₩277,000-9,000-3.1%₩287,500₩287,500₩277,000657,576
₩286,000-2,500-0.9%₩288,500₩290,500₩283,250481,793
₩288,500+5,500+1.9%₩290,500₩294,000₩284,250613,855
₩283,000-15,500-5.2%₩307,000₩313,500₩282,0001,248,714
₩298,500-2,500-0.8%₩293,000₩329,000₩291,0002,219,578
₩301,000-6,500-2.1%₩303,500₩306,000₩297,500281,391
₩307,500-12,500-3.9%₩311,000₩311,000₩293,000656,406
₩320,000+8,500+2.7%₩308,500₩324,500₩305,000615,333
₩311,50000.0%₩306,000₩317,500₩303,500368,961
₩311,500+6,000+2.0%₩305,000₩320,000₩296,500770,565
₩305,500-15,000-4.7%₩310,500₩313,500₩298,500318,030
₩320,500+500+0.2%₩319,000₩324,500₩314,000376,465
₩320,000-19,500-5.7%₩325,000₩328,000₩310,000491,494
₩339,500+36,000+11.9%₩333,000₩344,000₩322,0001,019,594

Splits

5 splits since 2017 · KRX:196170 · every price before a split is adjusted for it

DayRatioWhat
13-for-10Split
6-for-5Split
3-for-2Split
2-for-1Split
2-for-1Split
Ticker
KRX:196170
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
KRX
Currency
KRW

What changed lately

Latest news

All Alteogen Inc. news

Alteogen Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
3 in the last 12 months · 5 in all · newest Sep 2, 2026 · oldest 2025
Decks
3 decks · latest Apr 9, 2026

Valuation

P/E 63.2× against a median of 40.6×: 4th lowest of 6 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
₩11.68T KRW
P/E
63.2×
EV/sales
46.0×
EV/EBITDA
91.9×
Price/book
22.6×
Gross margin
80.9%
Operating margin
47.2%
Net margin
75.5%
Debt to equity
0.0×
Beta
No index for this market yet

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Alteogen Inc. · KRX:196170US$9.06BUS$8.73B63.2×46.0×91.9×22.6×75.5%0.0×n/a
Halozyme Therapeutics, Inc. · NASDAQ:HALOUS$10.41BUS$12.59B21.5×7.0×18.2×n/a26.9%n/a0.63
Kymera Therapeutics, Inc. · NASDAQ:KYMRUS$9.84BUS$8.87Bn/a86.8×n/a6.1×−341.8%0.0×0.92
TG Therapeutics, Inc. · NASDAQ:TGTXUS$9.70BUS$9.94B91.4×11.1×51.5×16.9×11.8%1.3×0.70
Krystal Biotech, Inc. · NASDAQ:KRYSUS$9.15BUS$8.24B40.6×17.5×35.3×6.4×47.9%0.0×0.69
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H · HKEX:6990US$8.99BUS$8.28B473×25.1×338×11.2×5.8%0.0×n/a
Spyre Therapeutics, Inc. · NASDAQ:SYREUS$8.88BUS$7.80Bn/a86.3×n/a8.4×−291.6%0.0×1.71
Vaxcyte, Inc. · NASDAQ:PCVXUS$8.77BUS$7.70Bn/an/an/a3.5×n/a0.1×1.24
Praxis Precision Medicines, Inc. · NASDAQ:PRAXUS$8.40BUS$7.65Bn/an/an/a6.7×n/a0.0×1.45
Summit Therapeutics Inc. · NASDAQ:SMMTUS$7.96BUS$7.33Bn/an/an/a14.1×n/a0.0×1.91
Protagonist Therapeutics, Inc. · NASDAQ:PTGXUS$7.92BUS$7.13B23.1×12.9×22.0×7.3×62.0%0.0×0.93
Median of the othersUS$8.93BUS$8.02B40.6×17.5×35.3×7.3×11.8%0.0×0.93

Forecasts

Analysts' consensus from EODHD, read Nov 21, 2026. Not 6ix's view and not investment advice.

Price target
358333.34 KRW · Analysts' mean
EPS, year to Dec 2026
3979.44 · 6 analysts
Revenue, year to Dec 2026
450.9B · 6 analysts

Team and board

OfficerRole
Junseok JangDirector, Investor Relations and Corporate Communications
Vivek ShenoyChief Business Officer

Events

QuarterResultsShare move
Quarter to Sep 30, 2026Nov 16, 2026 · Before open−2.5%
Q2 2026Aug 14, 2026−6.1%
Q1 2026May 11, 2026 · Before open−4.5%
Q4 2025Mar 23, 2026 · Before open−6.5%
Q3 2025Nov 13, 2025 · After close+0.9%
Q2 2025Aug 12, 2025 · Before open+1.1%
Q1 2025May 13, 2025 · Before open+3.6%
Q3 2024Nov 12, 2024 · After close−4.1%
Q2 2024Aug 14, 2024 · After close+2.9%
Q1 2024May 16, 2024 · After close+6.5%
All 20 quarters
QuarterResultsShare move
Q4 2023Mar 11, 2024 · After close+7.5%
Q3 2023Nov 14, 2023 · After close+10.4%
Q2 2023Aug 11, 2023 · After close−2.5%
Q1 2023May 15, 2023 · After close−2.2%
Q4 2022Mar 13, 2023 · Before open0.0%
Q3 2022Nov 11, 2022 · Before open+4.5%
Q2 2022Aug 12, 2022 · Before open−2.7%
Q1 2022May 16, 2022 · Before open+0.6%
Q3 2021Nov 15, 2021 · Before open−0.4%
Quarter to Jun 30, 2021Aug 17, 2021 · Before open−4.4%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (April 2026)Investor deck16 slidesApr 9, 2026
J.P. Morgan Healthcare Conference 2026Conference18 slidesJan 15, 2026
Korea Investment Week 2025Conference27 slidesSep 17, 2025

Open Decks

Financials

Annual, in KRW

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue215.9B102.9B96.5B28.8B41.1B42.4B29.2B13.7B12.1B6.84B
Cost of revenue50.2B38.8B65.3B24.3B33.0B23.7B18.1B11.7B11.1B6.21B
Gross profit165.6B64.1B31.2B4.53B8.17B18.8B11.1B1.96B1.03B629.4M
Research and development37.0B24.6B25.3B18.7B7.44B7.69B5.96B4.65B3.98B
Selling, general and administrative5.55B13.3B14.9B14.6B13.0B10.6B6.63B3.54B2.46B2.00B
Operating income106.9B22.9B-8.35B-18.3B-1.01B136.1M-2.25B-7.65B-7.71B-5.41B
Depreciation and amortization5.49B2.66B3.33B2.65B2.15B1.87B971.6M553.3M423.1M330.9M
EBITDA112.4B25.5B-5.01B-15.6B1.14B2.00B-1.28B-7.10B-7.29B-5.08B
Interest expense11.0B674.9M670.9M425.5M604.7M796.8M0000
Income before tax162.7B36.6B-3.56B-9.97B1.58B-2.84B-1.68B-6.03B-7.37B-4.46B
Income tax108.0M893.2M583.1M57.6M1.04B76.7M-869.0M
Net income141.7B62.3B-3.37B-8.15B6.00B-969.6M-704.5M-6.87B-7.45B-3.59B
Earnings per share, basic2,648.851,168.07-65.16-158.19141.85-23.02-16.90-181.19-196.90-96.08

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents66.4B19.0B30.2B45.8B10.5B38.9B4.41B8.92B5.23B8.39B
Short-term investments363.6B166.3B80.4B81.7B191.5B94.7B57.6B42.6B27.2B28.9B
Receivables4.81B17.2B14.3B7.31B2.08B1.56B1.84B4.63B1.45B1.65B
Inventory6.53B956.9M1.07B1.57B1.05B459.7M881.6M475.8M216.1M195.1M
Current assets480.8B211.8B144.1B139.3B210.2B137.9B65.2B58.3B35.7B39.3B
Property, plant and equipment19.6B19.3B27.2B29.6B19.5B19.2B11.7B5.03B4.73B
Goodwill113.0M113.0M113.0M113.0M113.0M113.0M113.0M113.0M113.0M
Total assets698.7B409.0B256.1B245.5B260.3B159.2B86.0B71.4B43.0B47.9B
Accounts payable11.2B10.0B1.01B159.5M1.41B440.2M1.03B1.62B1.30B1.51B
Current liabilities239.7B129.2B100.4B13.1B11.9B11.1B9.76B2.48B2.70B2.22B
Long-term debt4.03B5.00B1.25B687.5M937.5M687.5M1.00B1.50B
Total debt3.57B4.15B1.80B
Total liabilities244.3B134.9B108.3B96.7B123.6B28.0B16.0B4.76B3.17B2.72B
Shareholders' equity445.2B273.6B148.1B148.8B136.7B131.2B70.0B66.6B39.8B45.2B
Shares outstanding53.5M53.3M51.7M51.5M42.3M42.1M41.7M37.9M37.8M37.3M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations124.1B53.0B-7.77B-17.9B-9.46B1.51B9.13B-9.11B-4.35B-3.16B
Capital spending-33.4B-24.4B-43.4B-6.42B-13.6B-5.12B-8.16B-7.20B-706.5M-2.55B
Free cash flow90.7B28.6B-51.2B-60.4B-33.5B-3.82B-102.7M-16.3B-5.05B-5.71B
Cash from investing-107.8B-9.34B50.2B-125.9B-42.9B-22.0B-22.8B-319.1M-5.05B
Cash from financing43.3B1.74B2.92B107.0B76.1B8.63B35.4B1.67B9.39B
Share buybacks-1.37B27.1B2.39B2.56B2.93B76.4B6.44B33.6B1.67B9.48B
Change in cash47.4B-11.2B-15.6B35.3B-28.4B34.5B-4.50B3.69B-3.16B1.31B

Open Financials

Cap table

Built by 6ix from Alteogen Inc.’s releases · as of Jun 30, 2026

Common shares
69,513,590
Fully diluted
69,513,590

Fully diluted

LineSharesAs of
Common shares69,513,590Jun 30, 2026

Share count over time

CountShares
Jun 30, 202669,563,176

Open Cap table

Shareholders

HolderSharesValueAs of
Vanguard Total International Stock Index Fund586KUS$126MJul 31, 2026
iShares Core MSCI Emerging Markets ETF448KUS$110MMay 31, 2026
iShares MSCI South Korea ETF430KUS$105MMay 31, 2026
Vanguard Developed Markets Index Fund389KUS$91.1MJun 30, 2026
iShares MSCI Emerging Markets ex China ETF97,851US$23.9MMay 31, 2026
iShares MSCI Emerging Markets ETF95,077US$23.3MMay 31, 2026
Vanguard Ftse All-World Ex-Us Index Fund93,839US$20.1MJul 31, 2026
Schwab International Equity ETF87,331US$21.4MMay 31, 2026
Fidelity Series Global ex U.S. Index Fund79,879US$16.9MJul 31, 2026
iShares Core MSCI Total International Stock ETF54,884US$11.8MJul 31, 2026
Show 50 holders
HolderSharesValueAs of
Fidelity Emerging Markets Index Fund49,308US$10.4MJul 31, 2026
Vanguard Pacific Stock Index Fund42,940US$9.2MJul 31, 2026
State Street(R) SPDR(R) Portfolio Developed World ex-US ETF38,921US$9.07MJun 30, 2026
Vanguard Total World Stock Index Fund33,345US$7.15MJul 31, 2026
Nuveen Emerging Markets Equity Index Fund31,374US$6.72MJul 31, 2026
Franklin FTSE South Korea ETF30,282US$7.06MJun 30, 2026
Emerging Markets Core Equity 2 Portfolio24,949US$5.35MJul 31, 2026
Dimensional Emerging Core Equity Market ETF24,755US$5.36MJul 31, 2026
College Retirement Equities Fund - Total Global Stock Account24,283US$5.68MJun 30, 2026
Fidelity Total International Index Fund23,903US$5.06MJul 31, 2026
Fidelity Global ex U.S. Index Fund21,033US$4.45MJul 31, 2026
The Emerging Markets Series15,038US$3.22MJul 31, 2026
Dimensional Emerging Markets Core Equity 2 ETF14,251US$3.08MJul 31, 2026
iShares MSCI All Country Asia ex Japan ETF13,931US$2.99MJul 31, 2026
iShares MSCI ACWI ETF13,239US$2.84MJul 31, 2026
iShares MSCI ACWI ex U.S. ETF12,970US$2.78MJul 31, 2026
Fidelity ZERO International Index Fund12,942US$2.74MJul 31, 2026
Fidelity SAI Emerging Markets Index Fund12,122US$2.57MJul 31, 2026
State Street Global All Cap Equity ex-U.S. Index Portfolio11,242US$2.62MJun 30, 2026
College Retirement Equities Fund - Global Equities Account10,397US$2.43MJun 30, 2026
Emerging Markets Equity Index Fund9,617US$2.25MJun 30, 2026
WisdomTree Emerging Markets ex-State-Owned Enterprises Fund8,321US$1.94MJun 30, 2026
Vanguard ESG International Stock ETF7,802US$1.91MMay 31, 2026
Columbia EM Core ex-China ETF6,464US$1.51MJun 30, 2026
International Strategic Equity Allocation Fund5,546US$1.36MMay 31, 2026
iShares MSCI Emerging Markets Asia ETF5,223US$1.28MMay 31, 2026
Fidelity Flex International Index Fund4,627US$980KJul 31, 2026
Dimensional World ex. U.S. Core Equity 2 ETF4,255US$921KJul 31, 2026
Six Circles Managed Equity Portfolio International Unconstrained Fund4,245US$994KJun 30, 2026
JNL Emerging Markets Index Fund4,090US$959KJun 30, 2026
Avantis Emerging Markets Equity ETF3,978US$973KMay 31, 2026
NYLIM FTSE International Equity Currency Neutral ETF3,555US$769KJul 31, 2026
Emerging Markets Sustainability Core 1 Portfolio3,127US$670KJul 31, 2026
State Street(R) SPDR(R) MSCI ACWI ex-US ETF3,057US$712KJun 30, 2026
Emerging Markets Social Core Equity Portfolio2,828US$606KJul 31, 2026
John Hancock Multifactor Emerging Markets ETF2,637US$614KJun 30, 2026
Parametric Tax-Managed Emerging Markets Fund2,610US$611KJun 30, 2026
State Street Emerging Markets Equity Index Fund2,473US$576KJun 30, 2026
JPMorgan BetaBuilders Emerging Markets Equity ETF2,449US$525KJul 31, 2026
Total International Ex U.S. Index Master Portfolio2,403US$562KJun 30, 2026

This page holds 50 of 91 holders. Open Shareholders

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Junseok JangDirector, Investor Relations and Corporate Communications · Since at least Jun 10, 2026
Vivek ShenoyChief Business Officer · Since at least Sep 2, 2026

Open People

Log in to ask 6ix AI your own questions about Alteogen Inc.